Translational Health Sciences, University of Bristol Medical School, Bristol, UK.
Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
Syst Rev. 2023 Feb 15;12(1):20. doi: 10.1186/s13643-023-02182-9.
Techniques and devices for the endovascular treatment of peripheral arterial disease (PAD) are continuously evolving. High-quality clinical trials limit the variation in how endovascular interventions are described, performed and reported. The aim of this systematic review is to assess the quality of reporting standards in randomised controlled trials (RCTs) of endovascular lower limb interventions against the Consolidated Standards of Reporting Trials for Non-Pharmacologic Treatments (CONSORT-NPT) and template for intervention description and replication (TIDieR) framework.
Randomised trials including participants with peripheral arterial disease undergoing any infra-inguinal lower limb endovascular arterial intervention, searched from Medline, Embase and Cochrane Library databases from inception to December 2021, will be included. All study data, including details of the procedure investigated, will be extracted in keeping with the CONSORT-NPT and TIDieR checklist. Descriptive statistics will be used to summarise general study details and reporting standards of the trials.
The results will be used to inform the design of future RCTs in this area by optimising the way the interventions are described, standardised, and monitored. The systematic review will be disseminated via peer-reviewed manuscripts and presentations at relevant conferences.
PROSPERO CRD42022288214.
外周动脉疾病(PAD)的血管内治疗技术和器械不断发展。高质量的临床试验限制了血管内介入治疗描述、实施和报告的变化。本系统评价的目的是评估血管内下肢介入治疗随机对照试验(RCT)中报告标准的质量,以符合非药物治疗报告标准(CONSORT-NPT)和干预描述与复制模板(TIDieR)框架。
将纳入从 Medline、Embase 和 Cochrane 图书馆数据库中搜索到的,从成立到 2021 年 12 月期间,纳入患有外周动脉疾病并接受任何下肢血管内动脉腔内治疗的参与者的随机试验。将根据 CONSORT-NPT 和 TIDieR 清单提取所有研究数据,包括所研究手术的详细信息。将使用描述性统计数据总结试验的一般研究细节和报告标准。
研究结果将通过优化干预措施的描述、标准化和监测方式,为该领域未来的 RCT 设计提供信息。系统评价将通过同行评议的论文和相关会议上的报告进行传播。
PROSPERO CRD42022288214。